ABOUT

HISTORY

  • 2022
  • 07
    Series B - KDB Bank / DONG-A SOCIO HOLDINGS / KOLON Investment / KIWOOM Securities Co., Ltd. / CEO of the DB, Nam Ho Kim
    06
    LNP mass production technology patent application (Microfluidic technology)
    06
    MG-G101 patent application
    03
    MEPS-TBC cryopreservation patent grant
  • 2021
  • 11
    MG-PE3 PCT application
    09
    MEPS-TBC, Manufactured & Released
    08
    Series A (Bridge) – Korea Investment Partners Co., Ltd / SBI Investment Korea Co., Ltd. / KNOTUS Co., Ltd. / Tiumbio Co., Ltd
    04
    MG-PE3 patent granted in Republic of Korea
    03
    Started CRO evaluation of MG-PE3, new drug candidate for Alzheimer's disease - 1st Drug efficacy
    02
    Kicked off MEPS-BBB research service using new drug candidates with pharmaceutical companies
    01
    Expansion & relocation of the office, R&D center, and production facility (Hanyang Tower, 12, Beobwon-ro-11-gil, Songpa-gu, Seoul, Rep. of Korea)
  • 2020
  • 12
    Finished PK/PD CRO evaluation of MG-PE3, new drug candidate for Alzheimer's disease
    10
    Venture Business Certification
    08
    MEPS-TBC patent application (KR/US/PCT) & design application (KR/US/EU) MG-PE3 patent application (KR)
    08
    Series A – Korea Investment Partners Co., Ltd / Tiumbio Co., Ltd
    05
    Finalized technology transfer agreement with Georgia Tech. Registered Mepsgenlab as a subsidiary of Mepsgen
  • 2019
  • 12
    Angel investment
    09
    Founded Mepsgenlab Inc. (USA)
    08
    Founded Mepsgen Co., Ltd. (Rep. of Korea)

Sitemap닫기

ABOUT
OVERVIEW
HISTORY
LEADERSHIP
ORGANIZATION
CI
CONTACT
TECHNOLOGY
HUMAN ORGAN MODEL CHIP
NANOMEDICINE
NANOMANUFACTURING
PIPELINE
MEPS-X
MG-X
SERVICE
SERVICE
NEWS
NOTICE
MEDIA
ARTICLE